IoT and blockchain solution ensuring integrity of temperature-sensitive pharmaceuticals during transit. Real-time monitoring with predictive analytics reduces spoilage by 30% while automating compliance for €7.3B EU cold-chain market.
BioSupply Chain addresses the critical challenge of temperature deviations in pharmaceutical logistics through IoT sensors and blockchain verification. This end-to-end solution provides real-time monitoring, predictive analytics, and immutable audit trails for vaccines and biologics, reducing spoilage by 30% while ensuring regulatory compliance. Targeting pharmaceutical manufacturers and logistics providers, the platform transforms cold-chain transparency.
Core Functionality
IoT sensors continuously track temperature/humidity during transit while GPS provides real-time location data. Blockchain creates tamper-proof audit trails for compliance verification. Predictive analytics forecast potential spoilage events using machine learning algorithms. Cloud dashboard offers shipment visibility and automated GDP compliance reporting.
Target User and Segment
Primary users: Pharmaceutical manufacturers (vaccines, biologics), medical logistics providers, and biotech companies. Core segments:
- Enterprise: Large pharma with complex global supply chains
- Mid-market: Specialty drug manufacturers and clinical trial suppliers
Recommended Tech Stack
- IoT Layer: LoRaWAN sensors + GPS trackers
- Blockchain: Hyperledger Fabric permissioned ledger
- Backend: Python/Django with Kafka data streaming
- Analytics: TensorFlow ML models
- Frontend: React.js dashboard + Swift/Kotlin mobile apps
- Cloud: AWS IoT Core + S3 storage
Estimated MVP Hours and Costs
Total development: 1,200 hours @ €100/hour = €120,000
Breakdown:
- Sensor integration: 300h (€30,000)
- Blockchain module: 250h (€25,000)
- Analytics engine: 200h (€20,000)
- Dashboard: 250h (€25,000)
- Compliance reporting: 200h (€20,000)
+ Hardware prototyping: €25,000
Total MVP cost: €145,000
SWOT Analysis
- Strengths: Real-time intervention capability, automated compliance, 30% spoilage reduction, blockchain verification
- Weaknesses: Hardware dependency, specialized compliance expertise required, initial sensor costs
- Opportunities: €42B mRNA vaccine market by 2028, EU GDP mandates, expansion into food logistics
- Threats: Competition from Sensitech/ORBCOMM, carrier-owned solutions, GDPR/HIPAA compliance complexity
First 1000 Customers Strategy
Acquisition channels:
- Pharma conference sponsorships (€15k/event, 5% conversion)
- LinkedIn ABM targeting supply chain directors (€75 CPA)
- Partnerships with cold-chain packaging suppliers (revenue share)
- Freemium model for small biotechs
Budget: €220k acquisition cost
Conversion rate: 3.5% from qualified leads
Monetization
Business Model: Tiered SaaS + hardware-as-service
Pricing:
- Basic: €1,500/month (up to 50 shipments)
- Enterprise: €8,500/month (unlimited + premium support)
- + €15/sensor/month
Break-even: 180 enterprise clients
Revenue Projection: €1.2M Year 1 → €4.7M Year 2 (75% gross margin)
Core Team: 8 FTE (5 tech, 2 sales, 1 operations)
Market Positioning and Competitors
Market Size: €7.3B EU cold-chain logistics
Positioning: Blockchain-verified premium solution for compliance-critical shipments
Competitors:
- ELPRO (cloud-only monitoring)
- Berlinger (hardware-focused)
- Nektium (low-cost alternative)
Sales Strategy: Compliance-focused direct sales via logistics partners
Micro-niche: -80°C gene therapy transport with real-time intervention protocols
